scispace - formally typeset
A

Amit Singh

Researcher at National Institute of Technology, Patna

Publications -  773
Citations -  18812

Amit Singh is an academic researcher from National Institute of Technology, Patna. The author has contributed to research in topics: Digital watermarking & Medicine. The author has an hindex of 57, co-authored 640 publications receiving 13795 citations. Previous affiliations of Amit Singh include Ithaca College & Center for Infectious Disease Research and Policy.

Papers
More filters

SiCN nanomechanical resonators for array-based biosensor applications

TL;DR: In this paper, a SiCN doubly-clamped nanomechanical resonator array for the specific detection of proteins has been constructed and the resonant frequencies of individual resonators were determined using optical interferometry.
Journal ArticleDOI

Remodeling Yersinia pseudotuberculosis to generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague

TL;DR: Self-adjuvanting OMVs from a remodeled Yersinia pseudotuberculosis strain as a type of plague vaccine could diversify prophylactic choices and solve current vaccine limitations.
Posted ContentDOI

A prospective observational safety study on ChAdOx1 nCoV- 19 corona virus vaccine (recombinant) use in healthcare workers- first results from India

TL;DR: In this paper, the authors provided the first post approval safety data on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers in northern India (n=804).
Journal ArticleDOI

Clinical correlation of severe acute respiratory syndrome-coronavirus-2 cases in selected districts of Uttar Pradesh: A cross-sectional hospital-based study

TL;DR: In this article, a retrospective cross-sectional hospital-based study was performed on 1243 suspected cases of SARS-CoV-2 infection from March 25, 2020 to April 17, 2020 in the department of microbiology of our institute to know the correlation of various clinical features of severe acute respiratory syndrome CoV 2infected cases in selected districts of UP.
Patent

Novel forms of lumacaftor and processes for the preparation thereof

TL;DR: In this article, the authors provide amorphous lumacaftor dispersions, and processes for their preparation for the preparation of oral dosage forms for treating cystic fibrosis transmembrane conductance regulator (CFTR mediated diseases.